Literature DB >> 18357767

Coxsackievirus B RNA replication: lessons from poliovirus.

P Sean1, B L Semler.   

Abstract

The replication of coxsackievirus RNA occurs with rapid onset, starting approximately 2.5 h after infection. The mechanisms entailing the RNA replication of enteroviruses, like coxsackievirus and poliovirus, are highly conserved. These processes require two steps of RNA amplification: (i) complete synthesis of the negative-strand RNA using input RNA as the template and (ii) synthesis of the positive-strand RNA using the intermediate negative-strand RNA as the template. Successful enterovirus RNA replication requires all of the viral nonstructural proteins in their mature and precursor forms, as well as RNA secondary structures in the template. The encoded nonstructural proteins are responsible for RNA replication through multiple protein-protein interactions between viral and/or host proteins to mediate RNA synthesis, induce membranous vesicles, and deliver the replication complex to the template. The RNA secondary structures at the 5' and 3' termini of the template position the RNA replication complex at the initiation site(s) for both negative- and positive-strand RNA synthesis, thus providing binding sites for viral and host proteins that may functionally circularize the genome during RNA synthesis. Although considerable knowledge has been gained regarding the mechanism of enterovirus RNA synthesis, the complete steps in RNA replication have not been fully determined. The aim of this review is to summarize the current state of our knowledge and to present a model that encompasses the identified steps of enterovirus RNA replication.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18357767     DOI: 10.1007/978-3-540-75546-3_5

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  10 in total

1.  Immunodeficient mouse models with different disease profiles by in vivo infection with the same clinical isolate of enterovirus 71.

Authors:  Chun-Che Liao; An-Ting Liou; Ya-Shu Chang; Szu-Yao Wu; Chih-Shin Chang; Chien-Kuo Lee; John T Kung; Pang-Hsien Tu; Ya-Yen Yu; Chi-Yung Lin; Jen-Shiou Lin; Chiaho Shih
Journal:  J Virol       Date:  2014-08-20       Impact factor: 5.103

2.  Functional Consequences of RNA 5'-Terminal Deletions on Coxsackievirus B3 RNA Replication and Ribonucleoprotein Complex Formation.

Authors:  Nicolas Lévêque; Magali Garcia; Alexis Bouin; Joseph H C Nguyen; Genevieve P Tran; Laurent Andreoletti; Bert L Semler
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

3.  The crystal structure of coxsackievirus B3 RNA-dependent RNA polymerase in complex with its protein primer VPg confirms the existence of a second VPg binding site on Picornaviridae polymerases.

Authors:  Arnaud Gruez; Barbara Selisko; Michael Roberts; Gérard Bricogne; Cécile Bussetta; Ilham Jabafi; Bruno Coutard; Armando M De Palma; Johan Neyts; Bruno Canard
Journal:  J Virol       Date:  2008-07-16       Impact factor: 5.103

Review 4.  Cis-active RNA elements (CREs) and picornavirus RNA replication.

Authors:  Benjamin P Steil; David J Barton
Journal:  Virus Res       Date:  2008-09-20       Impact factor: 3.303

5.  GRP78/Dna K Is a Target for Nexavar/Stivarga/Votrient in the Treatment of Human Malignancies, Viral Infections and Bacterial Diseases.

Authors:  Jane L Roberts; Mehrad Tavallai; Aida Nourbakhsh; Abigail Fidanza; Tanya Cruz-Luna; Elizabeth Smith; Paul Siembida; Pascale Plamondon; Kelly A Cycon; Christopher D Doern; Laurence Booth; Paul Dent
Journal:  J Cell Physiol       Date:  2015-10       Impact factor: 6.384

6.  Mutational Disruption of cis-Acting Replication Element 2C in Coxsackievirus B3 Leads to 5'-Terminal Genomic Deletions.

Authors:  S Smithee; S Tracy; N M Chapman
Journal:  J Virol       Date:  2015-09-09       Impact factor: 5.103

7.  A functional nuclear localization sequence in the VP1 capsid protein of coxsackievirus B3.

Authors:  Tianying Wang; Bohai Yu; Lexun Lin; Xia Zhai; Yelu Han; Ying Qin; Zhiwei Guo; Shuo Wu; Xiaoyan Zhong; Yan Wang; Lei Tong; Fengmin Zhang; Xiaoning Si; Wenran Zhao; Zhaohua Zhong
Journal:  Virology       Date:  2012-09-23       Impact factor: 3.616

Review 8.  Development of Group B Coxsackievirus as an Oncolytic Virus: Opportunities and Challenges.

Authors:  Huitao Liu; Honglin Luo
Journal:  Viruses       Date:  2021-06-05       Impact factor: 5.048

9.  MiR-10a* up-regulates coxsackievirus B3 biosynthesis by targeting the 3D-coding sequence.

Authors:  Lei Tong; Lexun Lin; Shuo Wu; Zhiwei Guo; Tianying Wang; Ying Qin; Ruixue Wang; Xiaoyan Zhong; Xia Wu; Yan Wang; Tian Luan; Qiang Wang; Yunxia Li; Xiaofeng Chen; Fengmin Zhang; Wenran Zhao; Zhaohua Zhong
Journal:  Nucleic Acids Res       Date:  2013-02-06       Impact factor: 16.971

10.  EWSR1 binds the hepatitis C virus cis-acting replication element and is required for efficient viral replication.

Authors:  Todd E Oakland; Kyle J Haselton; Glenn Randall
Journal:  J Virol       Date:  2013-04-03       Impact factor: 5.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.